Robert E Weeks is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of antibiotics, holding a total of 4 patents. His work has had a profound impact on both human and animal health.

Latest Patents

One of his latest patents is the Antibiotic A-4696 factor G, a glycopeptide antibiotic produced by culturing the Actinoplanes missouriensis mutant strain ATCC 31681 under submerged aerobic fermentation conditions. This antibiotic is recovered from the fermentation broth through resin adsorption and chromatographic purification. A-4696G is known for its ability to inhibit the growth of bacteria that are pathogenic to both humans and animals. Additionally, it enhances the growth of ruminants by increasing feed utilization.

Career Highlights

Robert E Weeks is currently employed at Eli Lilly and Company, where he continues to innovate in the field of pharmaceuticals. His work at Eli Lilly has allowed him to focus on developing new antibiotics that address critical health challenges.

Collaborations

Throughout his career, Robert has collaborated with several talented individuals, including Kurt E Merkel and Manuel Debono. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Robert E Weeks is a distinguished inventor whose work in antibiotic development has made a significant impact on health and agriculture. His innovative contributions continue to shape the future of pharmaceuticals.